ArticleThe American journal of tropical medicine and hygiene2014
Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control.
Article in The American journal of tropical medicine and hygiene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 25 citations in OpenAlex.
- Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trial.The Lancet. Infectious diseases · 2025Trial
- Article
- Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis.Parasitology · 2022Article
- High concentrations of membrane-fed ivermectin are required for substantial lethal and sublethal impacts on Aedes aegypti.Parasites & vectors · 2021Article
- Ivermectin: repurposing a multipurpose drug for Venezuela's humanitarian crisis.International journal of antimicrobial agents · 2020Review
- Repurposing Drugs to Fight Hepatic Malaria Parasites.Molecules (Basel, Switzerland) · 2020Review
- Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.Clinical pharmacology and therapeutics · 2020Article
- A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool.The American journal of tropical medicine and hygiene · 2020Article
- Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparumAntimicrobial agents and chemotherapy · 2019Article
- High Throughput and Computational Repurposing for Neglected Diseases.Pharmaceutical research · 2018Review
- Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi.PLoS neglected tropical diseases · 2018Article
- Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi.Malaria journal · 2017Article
- Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles.Malaria journal · 2017Article
- Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways.Malaria journal · 2017Review
- Upon entering an age of global ivermectin-based integrated mass drug administration for neglected tropical diseases and malaria.Malaria journal · 2017Article
- Ivermectin: a complimentary weapon against the spread of malaria?Expert review of anti-infective therapy · 2017Review
- Inhibition of Plasmodium Liver Infection by Ivermectin.Antimicrobial agents and chemotherapy · 2017Article
- Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda.Malaria journal · 2015Article
- Differential effect of human ivermectin treatment on blood feeding Anopheles gambiae and Culex quinquefasciatus.Parasites & vectors · 2015Article
- Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments.Malaria journal · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
Abstract
Recently there have been calls for the eradication of malaria and the elimination of soil-transmitted helminths (STHs). Malaria and STHs overlap in distribution, and STH infections are associated with increased risk for malaria. Indeed, there is evidence that suggests that STH infection may facilitate malaria transmission. Malaria and STH coinfection may exacerbate anemia, especially in pregnant women, leading to worsened child development and more adverse pregnancy outcomes than these diseases would cause on their own. Ivermectin mass drug administration (MDA) to humans for malaria parasite transmission suppression is being investigated as a potential malaria elimination tool. Adding albendazole to ivermectin MDAs would maximize effects against STHs. A proactive, integrated control platform that targets malaria and STHs would be extremely cost-effective and simultaneously reduce human suffering caused by multiple diseases. This paper outlines the benefits of adding albendazole to ivermectin MDAs for malaria parasite transmission suppression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.